Company · institut-pasteur-8a5cbfb1
Institut Pasteur
4 sourcescompanies-2026-11-14-0.1.0
Cite this record
ConductScience Library. Institut Pasteur. Companies, record institut-pasteur-8a5cbfb1. Release companies-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/companies/institut-pasteur-8a5cbfb1
On this page
Company
The name as ClinicalTrials.gov gives it. A company is a name ClinicalTrials.gov classes as industry, and spellings that differ only in case or spacing are one; no subsidiary is folded into a parent. A trial of two phases counts in both, and recruiting trials count as active.
- Name
- Institut Pasteur
- Trials
- 182
- As lead sponsor
- 99
- As collaborator
- 83
- Recruiting
- 32
- Active, recruiting or not
- 57
- Completed
- 87
- Stopped early, withdrawn or suspended
- 11
- Posted results
- 1
- Trials by phase
- Phase 1 12, Phase 2 11, Phase 3 12, Phase 4 5
- Drugs its trials test
- 27
- Comparisons calculated in its trials
- 0
- First trial registered
- 2005-09-21
- Last update
- 2026-11-10
Source ClinicalTrials.gov
Pipeline27
The drugs its trials test, by the trial links the pipelines release's checks show. The phase is the highest phase those trials registered on ClinicalTrials.gov, not a development stage. Highest phase first, then the most trials.
1 to 10 of 27
See all 27 pipelineTrials182
The trials that name the company as lead sponsor or collaborator, newest registered first. Results posted are as ClinicalTrials.gov gave them on the day of the sponsors capture.
| Trial | Title | Role | Phase | Status | Type | Participants | Start | Results first posted | Drugs | In Trials | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT07928453 | Cardiovascular And Dementia Risk in diabeTes: the Role of Nox2- Related Oxidative Stress. | Collaborator | Recruiting | Observational | 250 | 2024-08-31 | https://conductscience.org/library/trials/NCT07928453 | ClinicalTrials.gov | |||
| NCT07921641 | Characterization of Adaptive Immune Responses to Oropouche Virus (OROV) Infection | Lead sponsor | Not yet recruiting | Observational | 80 | 2026-11-30 | https://conductscience.org/library/trials/NCT07921641 | ClinicalTrials.gov | |||
| NCT07898930 | Farm-originated Antimicrobial Resistance Modeling: Exploring Humans-to-Animal Dissemination | Collaborator | Not applicable | Not yet recruiting | Interventional | 20 | 2026-11 | https://conductscience.org/library/trials/NCT07898930 | ClinicalTrials.gov | ||
| NCT07882186 | Assessment of the Acceptability of, and Factors Associated With, Recommended Vaccinations During Pregnancy in Maternity Units in the Ile-de-France Region | Collaborator | Not yet recruiting | Observational | 1,605 | 2026-11 | https://conductscience.org/library/trials/NCT07882186 | ClinicalTrials.gov | |||
| NCT07833436 | A Trial to Evaluate the Safety, Immunogenicity and the Optimal Dose of MOPEVAC-Las Vaccine Candidate Against Lassa Fever | Lead sponsor | Phase 1 | Recruiting | Interventional | 72 | 2026-09-28 | https://conductscience.org/library/trials/NCT07833436 | ClinicalTrials.gov | ||
| NCT07770568 | Detection of Specific Metabolic Signatures by Nuclear Magnetic Resonance or Metabolomic NMR in Correlation With Markers of Inflammation or Immune Activation and the Risk of Developing Neurocognitive Disorders - Longitudinal Retrospective Study Nested in the ANRS12225 PEDIACAM III Cohort | Collaborator | Not yet recruiting | Observational | 128 | 2026-08 | https://conductscience.org/library/trials/NCT07770568 | ClinicalTrials.gov | |||
| NCT07740070 | Cognitive Processing of Natural Sequences in Humans and Artificial Intelligence (AI) | Lead sponsor | Not yet recruiting | Observational | 700 | 2026-09 | https://conductscience.org/library/trials/NCT07740070 | ClinicalTrials.gov | |||
| NCT07739433 | Investigating the Neural Oscillatory Features for Limited Access to Oral Language in Deaf Children With Early Bilateral Cochlear Implantation | Lead sponsor | Not yet recruiting | Observational | 150 | 2026-09 | https://conductscience.org/library/trials/NCT07739433 | ClinicalTrials.gov | |||
| NCT07692295 | Biomarkers for Post-treatment Control in HIV: International Study of the EU2Cure Research Consortium (Phase I) | Collaborator | Not yet recruiting | Observational | 200 | 2026-10 | https://conductscience.org/library/trials/NCT07692295 | ClinicalTrials.gov | |||
| NCT07677748 | Optimization of Perceived Sound Quality for Music Listening in Hearing Aid Users With Hearing Loss. | Lead sponsor | Not yet recruiting | Observational | 66 | 2026-09 | https://conductscience.org/library/trials/NCT07677748 | ClinicalTrials.gov |
1 to 10 of 182
See all 182 trialsConditions277
The conditions its trials name, as the trials write them, with case and spacing folded. The most trials first.
| Condition | Trials |
|---|---|
| COVID-19 | 7 |
| Arbovirus Infections | 6 |
| HIV | 6 |
| Chikungunya | 5 |
| Leptospirosis | 5 |
| Covid19 | 4 |
| Dengue | 4 |
| HIV Infections | 4 |
| Malaria | 4 |
| SARS-CoV Infection | 4 |
1 to 10 of 277Source ClinicalTrials.gov
See all 277 conditionsPartners318
The other organizations its trials name, as lead sponsor or collaborator, with the class ClinicalTrials.gov gives each. The most trials shared first. A partner that is a company opens its own record.
| Organization | Class | Trials shared | In Companies | Source |
|---|---|---|---|---|
| Assistance Publique - Hôpitaux de Paris | Other | 21 | ClinicalTrials.gov | |
| ANRS, Emerging Infectious Diseases | Other government | 13 | ClinicalTrials.gov | |
| Institut National de la Santé Et de la Recherche Médicale, France | Other government | 13 | ClinicalTrials.gov | |
| URC-CIC Paris Descartes Necker Cochin | Other | 9 | ClinicalTrials.gov | |
| Institut Pasteur de Madagascar | Other | 6 | ClinicalTrials.gov | |
| Institut de l'Audition | Other | 6 | ClinicalTrials.gov | |
| Centre Pasteur du Cameroun | Other | 5 | ClinicalTrials.gov | |
| National Institute of Hygiene and Epidemiology, Vietnam | Other | 5 | ClinicalTrials.gov | |
| University of Oxford | Other | 5 | ClinicalTrials.gov | |
| Centre Hospitalier Territorial de Nouvelle-Calédonie | Other | 4 | ClinicalTrials.gov |
1 to 10 of 318
See all 318 partnersData dates
The date of each source this release read.
Sources 4
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL
- ClinicalTrials.govNo license stated
- Open TargetsCC0 1.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBLCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this company from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/companies/v1/institut-pasteur-8a5cbfb1
GET https://conductscience.org/api/companies/v1/institut-pasteur-8a5cbfb1/pipeline?page=2